In Committee
Global Fairness in Drug Pricing Act
Sponsor
Rep. Khanna, Ro [D-CA-17]Democratic · CaliforniaCommittee
Judiciary CommitteeLast action
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
May 18, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · May 18, 2025
Introduced May 18, 2025
Members signed on after the sponsor
Offered against this measure
No roll calls stored
3 organizations reported lobbying on this bill.
From Lobbying Disclosure Act reports that name this bill. Reports do not say how much of a quarter's spending went to any one bill, so none is attributed here.